Abstract:Nonunion of fractures about the femoral neck and intertrochanteric hip regions is uncommon. Patients who develop nonunions of these fractures typically exhibit marked pain and disability, thereby presenting a treatment challenge to the orthopaedic surgeon. Factors that guide the choice of salvage treatment include the anatomic site of the nonunion, the quality of the remaining proximal bone and articular surface, and patient factors (such as age and activity level). In the younger patients with a well-preserve… Show more
“…Other associated risks of fixation include increased contralateral hip fractures [49] and complications and technical difficulties associated with salvage of failed fixation [16,23,34]. Despite the higher reoperation rates for internal fixation, advocates of this procedure argue this risk is offset by the benefits of preservation of the native femoral head and avoidance of potential complications of arthroplasty [2,13,31]. No clinical consensus exists regarding how to best treat FNFs with the primary intention of avoiding reoperation to avoid additional risks to patients.…”
Section: Discussionmentioning
confidence: 99%
“…The use of internal fixation in FNFs has been associated with reoperation rates ranging from 10% to 49% [18,21,22,24,42,44] compared with 0% to 24% for hemiarthroplasty [5,18,36,44], resulting in a more costly treatment strategy than hemiarthroplasty [1,25]. Despite increased complications and technical difficulties associated with salvage of failed fixation [16,23,34], some argue the higher reoperation rate is offset by the benefits of preservation of the native femoral head and avoidance of potential complications associated with arthroplasty [2,13,31]. Mortality at 1 year ranges from 14% to 36% but without differences in mortality between fixation and hemiarthroplasty at 1, 5, and 10 years [8,18,19,31,36,37].…”
Background Femoral neck fractures (FNFs) comprise 50% of geriatric hip fractures. Appropriate management requires surgeons to balance potential risks and associated healthcare costs with surgical treatment. Treatment complications can lead to reoperation resulting in increased patient risks and costs. Understanding etiologies of treatment failure and the population at risk may decrease reoperation rates. Questions/purposes We therefore (1) determined if treatment modality and/or displacement affected reoperation rates after FNF; and (2) identified factors associated with increased reoperation and timing and reasons for reoperation. Methods We reviewed 1411 records of patients older than 60 years treated for FNF with internal fixation or hemiarthroplasty between 1998 and 2009. We extracted patient age, sex, fracture classification, treatment modality and date, occurrence of and reasons for reoperation, comorbid conditions at the time of each surgery, and dates of death or last contact. Minimum followup was 12 months (median, 45 months; range, 12-157 months). Results Internal fixation (hazard ratio [HR], 6.38) and displacement (HR, 2.92) were independently associated with increased reoperation rates. The reoperation rate for nondisplaced fractures treated with fixation was 15% and for displaced fractures 38% after fixation and 7% after hemiarthroplasty. Most fractures treated with fixation underwent reoperation within 1 year primarily for nonunion. Most fractures treated with hemiarthroplasty underwent reoperation within 3 months, primarily for infection. Conclusions Overall, hemiarthroplasty resulted in fewer reoperations versus internal fixation and displaced fractures underwent reoperation more than nondisplaced. Our data suggest there are fewer reoperations when treating elderly patients with displaced FNFs with hemiarthroplasty than with internal fixation. Level of Evidence Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
“…Other associated risks of fixation include increased contralateral hip fractures [49] and complications and technical difficulties associated with salvage of failed fixation [16,23,34]. Despite the higher reoperation rates for internal fixation, advocates of this procedure argue this risk is offset by the benefits of preservation of the native femoral head and avoidance of potential complications of arthroplasty [2,13,31]. No clinical consensus exists regarding how to best treat FNFs with the primary intention of avoiding reoperation to avoid additional risks to patients.…”
Section: Discussionmentioning
confidence: 99%
“…The use of internal fixation in FNFs has been associated with reoperation rates ranging from 10% to 49% [18,21,22,24,42,44] compared with 0% to 24% for hemiarthroplasty [5,18,36,44], resulting in a more costly treatment strategy than hemiarthroplasty [1,25]. Despite increased complications and technical difficulties associated with salvage of failed fixation [16,23,34], some argue the higher reoperation rate is offset by the benefits of preservation of the native femoral head and avoidance of potential complications associated with arthroplasty [2,13,31]. Mortality at 1 year ranges from 14% to 36% but without differences in mortality between fixation and hemiarthroplasty at 1, 5, and 10 years [8,18,19,31,36,37].…”
Background Femoral neck fractures (FNFs) comprise 50% of geriatric hip fractures. Appropriate management requires surgeons to balance potential risks and associated healthcare costs with surgical treatment. Treatment complications can lead to reoperation resulting in increased patient risks and costs. Understanding etiologies of treatment failure and the population at risk may decrease reoperation rates. Questions/purposes We therefore (1) determined if treatment modality and/or displacement affected reoperation rates after FNF; and (2) identified factors associated with increased reoperation and timing and reasons for reoperation. Methods We reviewed 1411 records of patients older than 60 years treated for FNF with internal fixation or hemiarthroplasty between 1998 and 2009. We extracted patient age, sex, fracture classification, treatment modality and date, occurrence of and reasons for reoperation, comorbid conditions at the time of each surgery, and dates of death or last contact. Minimum followup was 12 months (median, 45 months; range, 12-157 months). Results Internal fixation (hazard ratio [HR], 6.38) and displacement (HR, 2.92) were independently associated with increased reoperation rates. The reoperation rate for nondisplaced fractures treated with fixation was 15% and for displaced fractures 38% after fixation and 7% after hemiarthroplasty. Most fractures treated with fixation underwent reoperation within 1 year primarily for nonunion. Most fractures treated with hemiarthroplasty underwent reoperation within 3 months, primarily for infection. Conclusions Overall, hemiarthroplasty resulted in fewer reoperations versus internal fixation and displaced fractures underwent reoperation more than nondisplaced. Our data suggest there are fewer reoperations when treating elderly patients with displaced FNFs with hemiarthroplasty than with internal fixation. Level of Evidence Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
“…8,9 Varus collapse and screw migration may cause loss of reduction, eventually leading to pain, limited joint mobility, leg length discrepancy, and limping. 6 Morbidity is reported to be closely related to the fracture healing complication rate.…”
Despite continued improvement in the methods and devices used to treat intertrochanteric fractures, there remains an unacceptable amount of failures. The cut-out rate for hip screws has been recorded up to 8.3%. To evaluate the migration of different implants under physiological loads, a multiplanar biomechanical test method for hip screws was developed, the first to incorporate a simulation of the human gait cycle by an oscillating flexion/extension movement of the test device. The new method was used to compare different hip screw and blade designs with respect to their directional migration resistance. The test method generated failure modes that were consistent with those observed clinically. Under cyclic loading, the hip screws migrated predominantly in a cephalad direction. In contrast, the helical blades exhibited a distinct migration in their axial direction. The Gamma3 hip screw design showed a significantly higher migration resistance compared with other screw and helical blade designs. The results demonstrate the ability of hip screws to significantly reduce axial migration and prevent cut-out under simulated walking loads. Further, the new multiplanar test method creates a physiological environment that can be used to optimize designs for intertrochanteric fracture fixation. ß
“…Union rates >90% can be seen with free vascularised fibular grafting [6][7][8]. Jun et al achieved union in 92.3% (24 of 26) cases in 5.3 months [6].…”
Section: Discussionmentioning
confidence: 94%
“…The technique involved nonvascular fibular graft with a cannulated cancellous screw [4]. Other studies report using two to three screws as supplemental fixation with a fibular graft [5][6][7][8][9]. Union rates with this technique in two different studies were 69% and 95% [4,5].…”
Angle blade plate provides rigid stability and offloads any shearing force over the fibular graft when used for revision internal fixation in aseptic femoral-neck nonunion. Thus, the fibular graft only serves the purpose of osteogenesis and stimulates the surrounding host cells to promote healing at the nonunion site. We recommend the angle blade plate and autogenous fibular graft as a viable option for hip-joint salvage in revision internal fixation of aseptic femoral-neck nonunion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.